These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12183796)

  • 1. [DNA flow cytometry of bone metastases of different primary tumors].
    Wohlrab D; Reichel H; Hein W
    Z Orthop Ihre Grenzgeb; 2002; 140(4):440-6. PubMed ID: 12183796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA image cytometry on sections compared with flow cytometry in human bone metastases.
    Wohlrab D; Klapperstück T; Holzhausen HJ; Held A; Hein W
    Oncol Rep; 2005 Oct; 14(4):1005-12. PubMed ID: 16142365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis.
    Ljungberg B
    Scand J Urol Nephrol Suppl; 1986; 100():1-47. PubMed ID: 3472340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
    Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
    Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast.
    Visscher DW; Zarbo RJ; Greenawald KA; Crissman JD
    Pathol Annu; 1990; 25 Pt 1():171-210. PubMed ID: 2153277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric DNA-ploidy and proliferative activity of diethylnitrosamine-induced hepatocellular carcinoma and pulmonary metastases in monkeys.
    Lapis K; Bocsi J; Lapis P; Thorgeirsson UP
    Hepatology; 1995 Sep; 22(3):952-61. PubMed ID: 7657303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA ploidy and proliferation heterogeneity in human prostate cancers.
    Shankey TV; Jin JK; Dougherty S; Flanigan RC; Graham S; Pyle JM
    Cytometry; 1995 Sep; 21(1):30-9. PubMed ID: 8529468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry.
    Zarbo RJ; Nakhleh RE; Brown RD; Kubus JJ; Ma CK; Mackowiak P
    Cancer; 1997 Jun; 79(11):2073-86. PubMed ID: 9179053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA and RNA content analysis by flow cytometry in the pathobiologic assessment of bone tumors.
    el-Naggar AK; Hurr K; Tu ZN; Teague K; Raymond KA; Ayala AG; Murray J
    Cytometry; 1995 Mar; 19(3):256-62. PubMed ID: 7736870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA flow cytometric analysis of clinical stage I endometrial carcinomas with lymph node metastases.
    Coleman RL; Schink JC; Miller DS; Bauer KD; August CZ; Rademaker AW; Lurain JR
    Gynecol Oncol; 1993 Jul; 50(1):20-4. PubMed ID: 8349159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence-based analysis of DNA ploidy and cell proliferation within fine-needle samplings of breast tumors: a new approach using automated image cytometry.
    Truong K; Vielh P; Malfoy B; Klijanienko J; Dutrillaux B; Bourgeois CA
    Cancer; 1998 Oct; 84(5):309-16. PubMed ID: 9801206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on nuclear DNA content in bladder cancers using flow cytometry].
    Toyota K
    Hokkaido Igaku Zasshi; 1996 Jan; 71(1):45-53. PubMed ID: 8727374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral heterogeneity in colorectal carcinoma: trucut sampling for DNA ploidy analysis.
    Giovagnoli MR; Giarnieri E; Midiri G; Tesoriere A; Ferraro S; Vecchione A
    Anticancer Res; 1999; 19(5C):4577-80. PubMed ID: 10650813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA analysis in advanced breast cancer.
    Leivonen M; Krogerus L; Nordling S
    Cancer Detect Prev; 1994; 18(2):87-96. PubMed ID: 8025900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA index as prognostic factor in breast cancer.
    Rzymowska J; Skierski J; Kurylcio L; Dyrda Z
    Neoplasma; 1995; 42(5):239-42. PubMed ID: 8552202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence cytophotometric measurements of nuclear DNA in adenocarcinoma of the lung; relation of proliferative activity and DNA ploidy to prognosis.
    Blöndal T; Lindgren A
    Anal Quant Cytol; 1982 Sep; 4(3):225-32. PubMed ID: 7149488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
    Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
    Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting metastasis of pheochromocytomas using DNA flow cytometry and immunohistochemical markers of cell proliferation: A positive correlation between MIB-1 staining and malignant tumor behavior.
    Brown HM; Komorowski RA; Wilson SD; Demeure MJ; Zhu YR
    Cancer; 1999 Oct; 86(8):1583-9. PubMed ID: 10526289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A flow cytometric study on giant cell tumor of bone.
    Guo W; Ren X; Feng C
    Chin Med J (Engl); 1996 Feb; 109(2):134-7. PubMed ID: 8758338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.